NO982414L - Ny kombinasjon - Google Patents

Ny kombinasjon

Info

Publication number: NO982414L
Authority: NO; Norway
Prior art keywords: active ingredient; new combination; kit; formoterol; budesonide
Prior art date: 1996-10-08

Application number

NO982414A

Other languages

English (en)

Norwegian (no)

Other versions

NO982414D0 (no

Inventor

Jan Trofast

Anders Ullman

Original Assignee

Astra Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-10-08

Filing date

1998-05-27

Publication date

1998-05-27

1998-05-27 Application filed by Astra Ab filed Critical Astra Ab

1998-05-27 Publication of NO982414D0 publication Critical patent/NO982414D0/no

1998-05-27 Publication of NO982414L publication Critical patent/NO982414L/no

Links

239000004480 active ingredient Substances 0.000 abstract 4
VOVIALXJUBGFJZ-KWVAZRHASA-N Budesonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C[C@H]3OC(CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O VOVIALXJUBGFJZ-KWVAZRHASA-N 0.000 abstract 1
229960004436 budesonide Drugs 0.000 abstract 1
BPZSYCZIITTYBL-UHFFFAOYSA-N formoterol Chemical compound C1=CC(OC)=CC=C1CC(C)NCC(O)C1=CC=C(O)C(NC=O)=C1 BPZSYCZIITTYBL-UHFFFAOYSA-N 0.000 abstract 1
229960002848 formoterol Drugs 0.000 abstract 1
208000023504 respiratory system disease Diseases 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
239000012453 solvate Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Otolaryngology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Plant Substances (AREA)
Medicinal Preparation (AREA)

NO982414A 1996-10-08 1998-05-27 Ny kombinasjon NO982414L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE9603669A SE9603669D0 (sv)	1996-10-08	1996-10-08	New combination
PCT/SE1997/001606 WO1998015280A1 (en)	1996-10-08	1997-09-24	New combination

Publications (2)

Publication Number	Publication Date
NO982414D0 NO982414D0 (no)	1998-05-27
NO982414L true NO982414L (no)	1998-05-27

Family

ID=20404167

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO982414A NO982414L (no)	1996-10-08	1998-05-27	Ny kombinasjon

Country Status (18)

Country	Link
EP (1)	EP0871450A1 (cs)
JP (1)	JP2000502365A (cs)
KR (1)	KR19990071975A (cs)
AR (1)	AR013614A1 (cs)
AU (1)	AU715319B2 (cs)
BR (1)	BR9706822A (cs)
CA (1)	CA2239308A1 (cs)
CZ (1)	CZ176198A3 (cs)
HU (1)	HUP9901674A3 (cs)
MY (1)	MY128337A (cs)
NO (1)	NO982414L (cs)
NZ (1)	NZ330482A (cs)
PL (1)	PL327037A1 (cs)
SE (1)	SE9603669D0 (cs)
SK (1)	SK75198A3 (cs)
TW (1)	TW470647B (cs)
WO (1)	WO1998015280A1 (cs)
ZA (1)	ZA978889B (cs)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE9700136D0 (sv) *	1997-01-20	1997-01-20	Astra Ab	New formulation
SE9700134D0 (sv) *	1997-01-20	1997-01-20	Astra Ab	New formulation
US5983956A (en) *	1994-10-03	1999-11-16	Astra Aktiebolag	Formulation for inhalation
US5980949A (en) *	1994-10-03	1999-11-09	Astra Aktiebolag	Formulation for inhalation
SE9700135D0 (sv) *	1997-01-20	1997-01-20	Astra Ab	New formulation
SE9700133D0 (sv) *	1997-01-20	1997-01-20	Astra Ab	New formulation
PL337722A1 (en) *	1997-06-27	2000-08-28	Astra Ab	Novel combination antiasthmatic drugs
SE9703407D0 (sv)	1997-09-19	1997-09-19	Astra Ab	New use
SE9802073D0 (sv)	1998-06-11	1998-06-11	Astra Ab	New use
US6451285B2 (en)	1998-06-19	2002-09-17	Baker Norton Pharmaceuticals, Inc.	Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant
US6290930B1 (en)	1998-12-18	2001-09-18	Baker Norton Pharmaceuticals, Inc.	Pharmaceutical solution aerosol formulations containing fluoroalkanes and budesonide
US6004537A (en) *	1998-12-18	1999-12-21	Baker Norton Pharmaceuticals, Inc.	Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol
SE9900834D0 (sv) *	1999-03-09	1999-03-09	Astra Ab	Novel combination
DE19921693A1 (de) *	1999-05-12	2000-11-16	Boehringer Ingelheim Pharma	Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika
ES2165768B1 (es)	1999-07-14	2003-04-01	Almirall Prodesfarma Sa	Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
GB0009584D0 (en) *	2000-04-18	2000-06-07	Glaxo Group Ltd	Pharmaceutical compositions
GB0012260D0 (en)	2000-05-19	2000-07-12	Astrazeneca Ab	Novel composition
FI20002216A0 (fi)	2000-10-06	2000-10-06	Orion Yhtymae Oyj	Yhdistelmäpartikkelit astman hoitoon
US6667344B2 (en)	2001-04-17	2003-12-23	Dey, L.P.	Bronchodilating compositions and methods
US20030055026A1 (en) *	2001-04-17	2003-03-20	Dey L.P.	Formoterol/steroid bronchodilating compositions and methods of use thereof
SE0200312D0 (sv)	2002-02-01	2002-02-01	Astrazeneca Ab	Novel composition
SE527069C2 (sv)	2003-06-19	2005-12-13	Mederio Ag	Förfarande och anordning för administrering av läkemedelspulver
TWI359675B (en)	2003-07-10	2012-03-11	Dey L P	Bronchodilating β-agonist compositions
US20050026887A1 (en) *	2003-07-29	2005-02-03	Boehringer Ingelheim International Gmbh	Medicaments for inhalation comprising an anticholinergic and a steroid
AU2007264418B2 (en)	2006-06-30	2012-05-03	Iceutica Pty Ltd	Methods for the preparation of biologically active compounds in nanoparticulate form
EP2124915A2 (en)	2007-02-19	2009-12-02	Cipla Limited	Pharmaceutical combinations of at least two bronchodilators or of a bronchodilator with a corticosteroid
EP2100599A1 (en)	2008-03-13	2009-09-16	Laboratorios Almirall, S.A.	Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
PL3111927T3 (pl)	2009-05-29	2020-06-29	Pearl Therapeutics, Inc.	Kompozycje do wziewnego podawania środków aktywnych oraz związane z nimi sposoby i systemy
EP2510928A1 (en)	2011-04-15	2012-10-17	Almirall, S.A.	Aclidinium for use in improving the quality of sleep in respiratory patients
US8633178B2 (en)	2011-11-23	2014-01-21	Therapeuticsmd, Inc.	Natural combination hormone replacement formulations and therapies
NZ629438A (en) *	2012-02-28	2016-10-28	Iceutica Holdings Inc	Inhalable pharmaceutical compositions
ITMI20130571A1 (it)	2013-04-10	2014-10-11	Zambon Spa	Composizione farmaceutica contenente budesonide e formoterolo
IT202000006442A1 (it)	2020-03-27	2021-09-27	Genetic S P A	Budesonide 21-phosphate salts and pharmaceutical compositions containing the same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK0613371T3 (da) *	1991-12-18	2002-05-13	Astrazeneca Ab	Ny kombination af formoterol og budesonid

1996
- 1996-10-08 SE SE9603669A patent/SE9603669D0/xx unknown
1997
- 1997-09-24 CA CA002239308A patent/CA2239308A1/en not_active Abandoned
- 1997-09-24 AU AU45782/97A patent/AU715319B2/en not_active Ceased
- 1997-09-24 BR BR9706822A patent/BR9706822A/pt not_active IP Right Cessation
- 1997-09-24 HU HU9901674A patent/HUP9901674A3/hu unknown
- 1997-09-24 EP EP97944242A patent/EP0871450A1/en not_active Withdrawn
- 1997-09-24 PL PL97327037A patent/PL327037A1/xx unknown
- 1997-09-24 WO PCT/SE1997/001606 patent/WO1998015280A1/en not_active Ceased
- 1997-09-24 SK SK751-98A patent/SK75198A3/sk unknown
- 1997-09-24 JP JP10517442A patent/JP2000502365A/ja active Pending
- 1997-09-24 KR KR1019980704266A patent/KR19990071975A/ko not_active Withdrawn
- 1997-09-24 CZ CZ981761A patent/CZ176198A3/cs unknown
- 1997-09-24 NZ NZ330482A patent/NZ330482A/xx unknown
- 1997-10-02 TW TW086114371A patent/TW470647B/zh not_active IP Right Cessation
- 1997-10-03 ZA ZA9708889A patent/ZA978889B/xx unknown
- 1997-10-07 AR ARP970104615A patent/AR013614A1/es not_active Application Discontinuation
- 1997-10-07 MY MYPI97004698A patent/MY128337A/en unknown
1998
- 1998-05-27 NO NO982414A patent/NO982414L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
TW470647B (en)	2002-01-01
CZ176198A3 (cs)	1998-09-16
ZA978889B (en)	1998-04-08
HUP9901674A2 (hu)	1999-09-28
AU715319B2 (en)	2000-01-20
HUP9901674A3 (en)	2001-04-28
SE9603669D0 (sv)	1996-10-08
KR19990071975A (ko)	1999-09-27
MY128337A (en)	2007-01-31
PL327037A1 (en)	1998-11-09
NZ330482A (en)	1999-11-29
WO1998015280A1 (en)	1998-04-16
AR013614A1 (es)	2001-01-10
NO982414D0 (no)	1998-05-27
SK75198A3 (en)	1998-11-04
JP2000502365A (ja)	2000-02-29
EP0871450A1 (en)	1998-10-21
CA2239308A1 (en)	1998-04-16
AU4578297A (en)	1998-05-05
BR9706822A (pt)	1999-03-23

Legal Events

Date	Code	Title	Description
2003-09-01	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO982414L (no)	1998-05-27	Ny kombinasjon
NO950774L (no)	1995-09-04	Fremgangsmåte for inhibering av bentap og nedsettelse av serumkolesterol
IS2788B (is)	2012-06-15	Búdesóníð- / formóterólefnablanda til innöndunar með lausa þéttni frá 0,30 til 0,36 g/ml, aðferð við að framleiða efnablönduna og notkun hennar
ES2182357T3 (es)	2003-03-01	Nueva utilizacion de budesonide y formoterol.
TR200003158T2 (tr)	2001-03-21	Jelleşebilen farmasötik bileşimler
HUP0104718A2 (hu)	2003-01-01	Mikronizált eplerenon kompozíciók és eljárás az előállításukra
NO952863D0 (no)	1995-07-19	Fluoxetin-farmasöytiske sammensetninger
NO20080284L (no)	2008-03-07	Cannabionoid aktiv farmasoytisk ingrediens for forbedrede doseringsformer
ATE339187T1 (de)	2006-10-15	Verwendung von zusammensetzungen mit antiseptika und/oder die wundheilung fördernden wirkstoffen für den tieferen atemwegstrakt
NO20012977D0 (no)	2001-06-15	N-ureidoalkylpiperidiner som modulatorer av chemokinreseptoraktivitet
NO20010833L (no)	2001-02-19	Orale mukoadhesive sammensetninger inneholdende gastrointestinale aktive bestanddeler
BR0211119A (pt)	2005-12-13	Composto, método de tratar um paciente que tenha, ou de prevenir um paciente de pegar, uma doença ou condição, uso de um composto, e, método para fabricar um composto
NO20050379L (no)	1997-09-26	Anvendelse av venlafaxinhydroklorid for fremstilling av en innkapslet forlenget frigjoringsblanding
PT948527E (pt)	2002-11-29	Novos derivados de ciclosporina sua preparacao e composicoes farmaceuticas que os contem
NO951498L (no)	1995-10-23	Farmasöytisk preparat for behandling av osteoporose
UY24308A1 (es)	1996-08-27	Tabletas exentas de aglutinante que contienen tramadol o una sal de tramadol, para administracion oral
IS2789B (is)	2012-06-15	Lyfjablöndur sem innihalda mónóamínoxídasa B hemla
EP1284265A4 (en)	2004-02-04	BENZOTHIOPHENE DERIVATIVES AND MEDICINAL USE THEREOF
ATE324112T1 (de)	2006-05-15	Topische behandlung bei der mastalgie
NO982989L (no)	1998-08-06	Anvendelse av inhibitorer av den cellulµre Na+/H+-utbytteren (NHE) for fremstilling av et medikament for respiratorstimulering
SE0002729D0 (sv)	2000-07-20	Novel compound form
BR0105787A (pt)	2002-05-28	Composição farmacêutica, uso de um composto farmacêutico, método para tratamento de distúrbios, composto farmacêutico e método para confeccionar um composto farmacêutico
EP0373771A3 (en)	1990-11-14	New pharmaceutical uses for cystatins
TR199700963T1 (xx)	1998-02-21	Kardiyovask�ler hastal�klar�n tedavisi i�in aminotetralin t�revi.
TR199900523T2 (xx)	1999-05-21	Vir�s k�kenli hastal�klar�n tedavisi i�in farmas�tik bile�imler.